T1	Pharmacological_substance 10 24	Antiretroviral
T2	Disorder 33 50	hepatic steatosis
N1 	Reference T2 UMLS:C2711227	hepatic steatosis
N2 	Reference T2 UMLS:C0015695	hepatic steatosis
T3	Disorder 55 70	lactic acidosis
N3 	Reference T3 UMLS:C0001125	lactic acidosis
T4	Disorder 136 180	human immunodeficiency virus (HIV) infection
N4 	Reference T4 UMLS:C0019693	human immunodeficiency virus (HIV) infection
T5	Disorder 292 299	colitis
N5 	Reference T5 UMLS:C0009319	colitis
T6	Disorder 303 312	enteritis
N6 	Reference T6 UMLS:C0014335	enteritis
T7	Disorder 369 376	abscess
N7 	Reference T7 UMLS:C0000833	abscess
T8	Disorder 394 413	mesenteric ischemia
N8 	Reference T8 UMLS:C1412000	mesenteric ischemia
T9	Disorder 435 460	fulminant hepatic failure
N9 	Reference T9 UMLS:C0162557	fulminant hepatic failure
T10	Pharmacological_substance 477 487	didanosine
N1000 	Reference T10 MeSH:D016049	didanosine
T11	Disorder 694 707	acute abdomen
N10 	Reference T11 UMLS:C0000727	acute abdomen
T13	Disorder 378 389	perforation
N11 	Reference T13 UMLS:C0549099	perforation
T14	Subject 715 735	HIV-positive patient
